REVIEW article
Front. Neurol.
Sec. Neurogenetics
Volume 16 - 2025 | doi: 10.3389/fneur.2025.1662012
This article is part of the Research TopicPsychiatric Comorbidities of Neurogenetic and Neurodegenerative DiseasesView all 3 articles
CADASIL or NOTCH3 mutaion spectrum diseases? Interpretation of NOTCH3 mutations and clinical heterogeneity in CADASIL
Provisionally accepted- First Affiliated Hospital of Jilin University, Changchun, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an autosomal dominant disorder characterized by midlife-onset cerebrovascular disease and dementia. It is caused by mutations in the NOTCH3 gene, which affects the amount of cysteine in the extracellular domain (ECD) of the receptor, leading to protein misfolding and receptor aggregation. Emerging evidence indicates that beyond classical missense mutations, other variants including cysteine-sparing missense mutations, homozygous mutations, small deletions, duplications, splice site mutations, a deletion/insertion and loss-of-function mutations may lead to distinct phenotypes with variable severity and disease penetrance. The marked heterogeneity in genotypes and phenotypes poses significant challenges for CADASIL diagnosis and clinical management. The aim of this review is to summarize the mutational spectrum of CADASIL, explore the possible genotype-phenotype correlations and discuss the phenotypic heterogeneity of NOTCH3 mutations. More studies are needed in the future to demonstrate whether CADASIL can be expanded from classical cerebral small vessel disease to a new spectrum of diseases that share the same pathogenesis as mutations in the NOTCH3 gene.
Keywords: CADASIL, Notch3, NOTCH3 mutaion spectrum diseases, Hereditary cerebral small vessel disease, the phenotypic heterogeneity
Received: 08 Jul 2025; Accepted: 03 Sep 2025.
Copyright: © 2025 Wang, Liu, Mo, Han, Jing and Deng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Fang Deng, First Affiliated Hospital of Jilin University, Changchun, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.